ARCHIVES

NCI Plans Trials of Burzynski’s ‘Antineoplaston’; JAMA Report Says No Antitumor Activity In Tests

This article is from The Cancer Letter archive.

Vol. 18 No. 23 | June 5, 1992

Download PDF Visit The Full Archive

Related Articles

In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs

January 17, 1992

New Research Projects Proposed For Immunology

September 30, 1977

Funding Opportunities.

April 11, 2003

Clinical Education Guidelines Proposed

April 4, 1975

The White House: President’s Proclamation For Breast Cancer Awareness Month

October 9, 1998

Denman Hammond, NCCF Founder, Receives Award.

November 17, 2000